Reuters logo
BRIEF-Basilea Pharmaceutica awarded $54.8 mln of additional funding by BARDA
2017年6月13日 / 凌晨5点21分 / 3 个月前

BRIEF-Basilea Pharmaceutica awarded $54.8 mln of additional funding by BARDA

June 13 (Reuters) - BASILEA PHARMACEUTICA AG:

* BASILEA AWARDED USD 54.8 MILLION OF ADDITIONAL FUNDING BY BARDA TO SUPPORT PHASE 3 DEVELOPMENT OF CEFTOBIPROLE

* ‍TOTAL POTENTIAL FUNDING OF UP TO APPROXIMATELY USD 108 MILLION UNDER CONTRACT WILL ENABLE BASILEA TO CONDUCT TWO CLINICAL PHASE 3 STUDIES​

* ‍TOTAL VALUE OF CONTRACT COULD REACH APPROXIMATELY USD 108 MILLION OVER A PERIOD OF 4.5 YEARS IF PRE-DEFINED MILESTONES ARE MET​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below